Skip to main content

Peer Review reports

From: Efficacy and safety of anlotinib monotherapy or combination therapy in the treatment of patients with advanced non-small cell lung cancer: a retrospective real-world study conducted in East China

Original Submission
3 Dec 2024 Submitted Original manuscript
12 Feb 2025 Reviewed Reviewer Report
21 Feb 2025 Reviewed Reviewer Report
18 Mar 2025 Author responded Author comments - Jingjing Ding
Resubmission - Version 2
18 Mar 2025 Submitted Manuscript version 2
27 Mar 2025 Author responded Author comments - Jingjing Ding
Resubmission - Version 3
27 Mar 2025 Submitted Manuscript version 3
28 Mar 2025 Author responded Author comments - Jingjing Ding
Resubmission - Version 4
28 Mar 2025 Submitted Manuscript version 4
Publishing
28 Mar 2025 Editorially accepted
10 Apr 2025 Article published 10.1186/s12890-025-03635-8

You can find further information about peer review here.

Back to article page